en

PRODUCT DETAIL

Alunbrig 180 mg filmom obalené tablety

Code 9789C
MA number EU/1/18/1264/009
Product Form: tbl flm 30x180 mg (fľ.HDPE)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01ED Anaplastic lymphoma kinase (ALK) inhibitors
L01ED04 Brigatinib
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 22.11.2018
Validity: 22.11.2023
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 08.11.2022
eu-flag.png sk-flag.png